Cargando…

Amyloid Beta-Mediated Epigenetic Alteration of Insulin-Like Growth Factor Binding Protein 3 Controls Cell Survival in Alzheimer's Disease

Swedish double mutation (KM670/671NL) of amyloid precursor protein (APP) is reported to increase toxic amyloid β (Aβ) production via aberrant cleavage at the β-secretase site and thereby cause early-onset Alzheimer's disease (AD). However, the underlying molecular mechanisms leading to AD patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Hye Youn, Choi, Eun Nam, Lyu, Dahyun, Mook-Jung, Inhee, Ahn, Jung-Hyuck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070895/ https://www.ncbi.nlm.nih.gov/pubmed/24964199 http://dx.doi.org/10.1371/journal.pone.0099047

Ejemplares similares

Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer’s Disease
por: Sung, Hye Youn, et al.
Publicado: (2016)

HDAC6 Inhibitor Blocks Amyloid Beta-Induced Impairment of Mitochondrial Transport in Hippocampal Neurons
por: Kim, Chaeyoung, et al.
Publicado: (2012)

Acute ER stress regulates amyloid precursor protein processing through ubiquitin-dependent degradation
por: Jung, Eun Sun, et al.
Publicado: (2015)

Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
por: Jeon, Seong Gak, et al.
Publicado: (2018)

Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
por: Han, Sun-Ho, et al.
Publicado: (2011)

Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
por: Han, Sun-Ho, et al.
Publicado: (2014)

The clinical use of blood-test factors for Alzheimer’s disease: improving the prediction of cerebral amyloid deposition by the QPLEX(TM)Alz plus assay kit
por: Kim, Haeng Jun, et al.
Publicado: (2021)

Cytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway
por: Liu, Tian, et al.
Publicado: (2017)

The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease
por: Kim, Dong Kyu, et al.
Publicado: (2019)

Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
por: Park, Jong-Chan, et al.
Publicado: (2017)

Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease
por: Park, Jong-Chan, et al.
Publicado: (2023)

Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review
por: Park, Jong-Chan, et al.
Publicado: (2020)

Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology
por: Kim, Taewon, et al.
Publicado: (2022)

Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer
por: Sung, Hye Youn, et al.
Publicado: (2017)

Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition
por: Park, Jong-Chan, et al.
Publicado: (2021)

Amyloid‐β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk‐AMPK pathway
por: Jung, Eun Sun, et al.
Publicado: (2022)

Disruption of blood-brain barrier in Alzheimer disease pathogenesis
por: Kook, Sun-Young, et al.
Publicado: (2013)

Natural Products Targeting Amyloid Beta in Alzheimer’s Disease
por: Lee, Joo-Hee, et al.
Publicado: (2021)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer’s disease pathogenesis
por: Li, Nuo-Min, et al.
Publicado: (2019)

Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway
por: Son, Sung Min, et al.
Publicado: (2015)

Altered APP Processing in Insulin-Resistant Conditions Is Mediated by Autophagosome Accumulation via the Inhibition of Mammalian Target of Rapamycin Pathway
por: Son, Sung Min, et al.
Publicado: (2012)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Application of QPLEX(TM) biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition
por: Lee, Dongjoon, et al.
Publicado: (2022)

Mimicry of Central-Peripheral Immunity in Alzheimer's Disease and Discovery of Neurodegenerative Roles in Neutrophil
por: Park, Joseph, et al.
Publicado: (2019)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-β Production in Alzheimer's Disease
por: Zuo, Li, et al.
Publicado: (2015)

Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression
por: Findley, Caleigh A., et al.
Publicado: (2019)

Familial Alzheimer’s Disease-Related Mutations Differentially Alter Stability of Amyloid-Beta Aggregates
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2023)

Serum zinc levels and in vivo beta-amyloid deposition in the human brain
por: Kim, Jee Wook, et al.
Publicado: (2021)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

Gut microbiome alterations in preclinical Alzheimer’s disease
por: Jung, Joon Hyung, et al.
Publicado: (2022)

Epigenetic modification of α-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer
por: Ha, Ye-Na, et al.
Publicado: (2018)

Crocus-derived compounds alter the aggregation pathway of Alzheimer’s Disease: associated beta amyloid protein
por: Koulakiotis, Nikolaos Stavros, et al.
Publicado: (2020)

Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
por: Burns, Lindsay H., et al.
Publicado: (2017)

Special issue on neurodegenerative diseases and their therapeutic approaches
por: Kim, Jungsu, et al.
Publicado: (2015)

PRAK mediates Aβ-RAGE driven autophagy pathway
por: Kim, Yoonhee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pt5sb3uk2f5tb3qhcehaec1v9m